Maddox Edwards has concluded a five-day bench trial before Chief Judge Stark on behalf of Amneal Pharmaceuticals. The drug product at issue is Amneal’s proposed generic version of Epaned®, an ACE inhibitor approved for treatment of hypertension. The trial was held remotely via video-conference.
At trial, Maddox Edwards attorneys presented several defenses, including non-infringement and invalidity of the asserted patents due to obviousness, lack of written description, and lack of enablement. A decision is expected later this year.